Literature DB >> 35477559

Long-term effect of asthma on the development of obesity among adults: an international cohort study, ECRHS.

Subhabrata Moitra1,2,3,4, Anne-Elie Carsin2,3,4, Michael J Abramson5, Simone Accordini6, Andre F S Amaral7, Josep Anto2,3,4, Roberto Bono8, Lidia Casas Ruiz9,10, Isa Cerveri11, Leda Chatzi12,13,14, Pascal Demoly15,16, Sandra Dorado-Arenas17, Bertil Forsberg18, Frank Gilliland13, Thorarinn Gislason19,20, Jose A Gullón21, Joachim Heinrich22,23, Mathias Holm24, Christer Janson25, Rain Jogi26, Francisco Gómez Real27,28, Debbie Jarvis29, Bénédicte Leynaert30,31, Dennis Nowak22, Nicole Probst-Hensch32,33, José Luis Sánchez-Ramos34, Chantal Raherison-Semjen35, Valerie Siroux36, Stefano Guerra37, Manolis Kogevinas2,3,4, Judith Garcia-Aymerich2,3,4.   

Abstract

INTRODUCTION: Obesity is a known risk factor for asthma. Although some evidence showed asthma causing obesity in children, the link between asthma and obesity has not been investigated in adults.
METHODS: We used data from the European Community Respiratory Health Survey (ECRHS), a cohort study in 11 European countries and Australia in 3 waves between 1990 and 2014, at intervals of approximately 10 years. We considered two study periods: from ECRHS I (t) to ECRHS II (t+1), and from ECRHS II (t) to ECRHS III (t+1). We excluded obese (body mass index≥30 kg/m2) individuals at visit t. The relative risk (RR) of obesity at t+1 associated with asthma at t was estimated by multivariable modified Poisson regression (lag) with repeated measurements. Additionally, we examined the association of atopy and asthma medication on the development of obesity.
RESULTS: We included 7576 participants in the period ECRHS I-II (51.5% female, mean (SD) age of 34 (7) years) and 4976 in ECRHS II-III (51.3% female, 42 (8) years). 9% of participants became obese in ECRHS I-II and 15% in ECRHS II-III. The risk of developing obesity was higher among asthmatics than non-asthmatics (RR 1.22, 95% CI 1.07 to 1.38), and particularly higher among non-atopic than atopic (1.47; 1.17 to 1.86 vs 1.04; 0.86 to 1.27), those with longer disease duration (1.32; 1.10 to 1.59 in >20 years vs 1.12; 0.87 to 1.43 in ≤20 years) and those on oral corticosteroids (1.99; 1.26 to 3.15 vs 1.15; 1.03 to 1.28). Physical activity was not a mediator of this association.
CONCLUSION: This is the first study showing that adult asthmatics have a higher risk of developing obesity than non-asthmatics, particularly those non-atopic, of longer disease duration or on oral corticosteroids. © Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  Asthma; Asthma Epidemiology; Clinical Epidemiology

Year:  2022        PMID: 35477559     DOI: 10.1136/thoraxjnl-2021-217867

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  1 in total

1.  Prevalence of asthma and COPD in a cohort of patients at the follow up after COVID-19 pneumonia.

Authors:  A Verduri; J Hewitt; B Carter; R Tonelli; E Clini; B Beghè
Journal:  Pulmonology       Date:  2022-06-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.